A Role for Zic1 and Zic2 in Myf5 Regulation and Somite Myogenesis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Complete Genome Sequences, Unique Mutational Spectra, and Developmental Potency of Adult Neurons Revealed by Cloning
Article The Complete Genome Sequences, Unique Mutational Spectra, and Developmental Potency of Adult Neurons Revealed by Cloning Highlights Authors d Reprogramming neurons by cloning enables high-fidelity Jennifer L. Hazen, Gregory G. Faust, whole-genome sequencing Alberto R. Rodriguez, ..., Sergey Kupriyanov, Ira M. Hall, d Neurons harbor 100 unique mutations but lack recurrent Kristin K. Baldwin DNA rearrangements Correspondence d Neuronal mutations impact expressed genes and exhibit unique molecular signatures [email protected] (I.M.H.), [email protected] (K.K.B.) d Mature adult neurons can generate fertile adult mouse clones In Brief Hazen et al. use cloning to amplify and perform complete genome sequence analyses on adult neurons. They discover unique characteristics of neuronal genomes consistent with postmitotic mutation and further establish neuronal genomic integrity by generating fertile mice from these neurons. Hazen et al., 2016, Neuron 89, 1223–1236 March 16, 2016 ª2016 Elsevier Inc. http://dx.doi.org/10.1016/j.neuron.2016.02.004 Neuron Article The Complete Genome Sequences, Unique Mutational Spectra, and Developmental Potency of Adult Neurons Revealed by Cloning Jennifer L. Hazen,1,8 Gregory G. Faust,2,8 Alberto R. Rodriguez,3 William C. Ferguson,1 Svetlana Shumilina,2 Royden A. Clark,2 Michael J. Boland,1 Greg Martin,3 Pavel Chubukov,1,4 Rachel K. Tsunemoto,1,5 Ali Torkamani,4 Sergey Kupriyanov,3 Ira M. Hall,6,7,* and Kristin K. Baldwin1,5,* 1Department of Molecular and Cellular Neuroscience, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA 2Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, 1340 Jefferson Park Avenue, Charlottesville, VA 22901, USA 3Mouse Genetics Core Facility 4Department of Integrative Structural and Computational Biology The Scripps Research Institute, 10550 N. -
Genome-Wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3Q Gain for Detection of Cervical Precancer and Cancer
Published OnlineFirst January 24, 2017; DOI: 10.1158/1078-0432.CCR-16-2641 Biology of Human Tumors Clinical Cancer Research Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer Wina Verlaat1, Peter J.F. Snijders1, Putri W. Novianti1,2, Saskia M. Wilting1, Lise M.A. De Strooper1, Geert Trooskens3, Johan Vandersmissen3, Wim Van Criekinge3, G. Bea A. Wisman4, Chris J.L.M. Meijer1, Danielle€ A.M. Heideman1, and Renske D.M. Steenbergen1 Abstract Purpose: Epigenetic host cell changes involved in cervical PCR (MSP) resulted in 3 genes (GHSR, SST, and ZIC1) that cancer development following a persistent high-risk human pap- showed a significant increase in methylation with severity of illomavirus (hrHPV) infection, provide promising markers for the disease in both tissue specimens and cervical scrapes (P < management of hrHPV-positive women. In particular, markers 0.005). The area under the ROC curve for CIN3 or worse varied based on DNA methylation of tumor suppressor gene promoters between 0.86 and 0.89. Within the group of CIN2/3, methylation are valuable. These markers ideally identify hrHPV-positive wom- levels of all 3 genes increased with duration of lesion existence en with precancer (CIN2/3) in need of treatment. Here, we set out (P < 0.0005), characterized by duration of preceding hrHPV to identify biologically relevant methylation markers by genome- infection, and were significantly higher in the presence of a 3q wide methylation analysis of both hrHPV-transformed cell lines gain (P < 0.05) in the corresponding tissue biopsy. and cervical tissue specimens. -
ZIC1 Monoclonal Antibody (M08), Clone 1A8
ZIC1 monoclonal antibody (M08), clone 1A8 Catalog # : H00007545-M08 規格 : [ 100 ug ] List All Specification Application Image Product Mouse monoclonal antibody raised against a full length recombinant Western Blot (Cell lysate) Description: ZIC1. Immunogen: ZIC1 (NP_003403, 139 a.a. ~ 212 a.a) full length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. Sequence: GHLLFPGLHEQAAGHASPNVVNGQMRLGFSGDMYPRPEQYGQVTSPR SEHYAAPQLHGYGPMNVNMAAHHGAGA enlarge Western Blot (Recombinant Host: Mouse protein) Reactivity: Human, Rat ELISA Isotype: IgG2b Kappa Quality Control Antibody Reactive Against Recombinant Protein. Testing: Western Blot detection against Immunogen (34.14 KDa) . Storage Buffer: In 1x PBS, pH 7.4 Storage Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. Instruction: MSDS: Download Datasheet: Download Applications Western Blot (Cell lysate) Page 1 of 2 2016/5/22 ZIC1 monoclonal antibody (M08), clone 1A8. Western Blot analysis of ZIC1 expression in PC-12. Protocol Download Western Blot (Recombinant protein) Protocol Download ELISA Gene Information Entrez GeneID: 7545 GeneBank NM_003412 Accession#: Protein NP_003403 Accession#: Gene Name: ZIC1 Gene Alias: ZIC,ZNF201 Gene Zic family member 1 (odd-paired homolog, Drosophila) Description: Omim ID: 600470 Gene Ontology: Hyperlink Gene Summary: This gene encodes a member of the ZIC family of C2H2-type zinc finger proteins. Members of this family are important during development. Aberrant expression of this gene is seen in medulloblastoma, a childhood brain tumor. This gene is closely linked to the gene encoding zinc finger protein of the cerebellum 4, a related family member on chromosome 3. This gene encodes a transcription factor that can bind and transactivate the apolipoprotein E gene. -
1A Multiple Sclerosis Treatment
The Pharmacogenomics Journal (2012) 12, 134–146 & 2012 Macmillan Publishers Limited. All rights reserved 1470-269X/12 www.nature.com/tpj ORIGINAL ARTICLE Network analysis of transcriptional regulation in response to intramuscular interferon-b-1a multiple sclerosis treatment M Hecker1,2, RH Goertsches2,3, Interferon-b (IFN-b) is one of the major drugs for multiple sclerosis (MS) 3 2 treatment. The purpose of this study was to characterize the transcriptional C Fatum , D Koczan , effects induced by intramuscular IFN-b-1a therapy in patients with relapsing– 2 1 H-J Thiesen , R Guthke remitting form of MS. By using Affymetrix DNA microarrays, we obtained and UK Zettl3 genome-wide expression profiles of peripheral blood mononuclear cells of 24 MS patients within the first 4 weeks of IFN-b administration. We identified 1Leibniz Institute for Natural Product Research 121 genes that were significantly up- or downregulated compared with and Infection Biology—Hans-Knoell-Institute, baseline, with stronger changed expression at 1 week after start of therapy. Jena, Germany; 2University of Rostock, Institute of Immunology, Rostock, Germany and Eleven transcription factor-binding sites (TFBS) are overrepresented in the 3University of Rostock, Department of Neurology, regulatory regions of these genes, including those of IFN regulatory factors Rostock, Germany and NF-kB. We then applied TFBS-integrating least angle regression, a novel integrative algorithm for deriving gene regulatory networks from gene Correspondence: M Hecker, Leibniz Institute for Natural Product expression data and TFBS information, to reconstruct the underlying network Research and Infection Biology—Hans-Knoell- of molecular interactions. An NF-kB-centered sub-network of genes was Institute, Beutenbergstr. -
Chromosome 13 Introduction Chromosome 13 (As Well As Chromosomes 14, 15, 21 and 22) Is an Acrocentric Chromosome. Short Arms Of
Chromosome 13 ©Chromosome Disorder Outreach Inc. (CDO) Technical genetic content provided by Dr. Iosif Lurie, M.D. Ph.D Medical Geneticist and CDO Medical Consultant/Advisor. Ideogram courtesy of the University of Washington Department of Pathology: ©1994 David Adler.hum_13.gif Introduction Chromosome 13 (as well as chromosomes 14, 15, 21 and 22) is an acrocentric chromosome. Short arms of acrocentric chromosomes do not contain any genes. All genes are located in the long arm. The length of the long arm is ~95 Mb. It is ~3.5% of the total human genome. Chromosome 13 is a gene poor area. There are only 600–700 genes within this chromosome. Structural abnormalities of the long arm of chromosome 13 are very common. There are at least 750 patients with deletions of different segments of the long arm (including patients with an associated imbalance for another chromosome). There are several syndromes associated with deletions of the long arm of chromosome 13. One of these syndromes is caused by deletions of 13q14 and neighboring areas. The main manifestation of this syndrome is retinoblastoma. Deletions of 13q32 and neighboring areas cause multiple defects of the brain, eye, heart, kidney, genitalia and extremities. The syndrome caused by this deletion is well known since the 1970’s. Distal deletions of 13q33q34 usually do not produce serious malformations. Deletions of the large area between 13q21 and 13q31 do not produce any stabile and well–recognized syndromes. Deletions of Chromosome 13 Chromosome 13 (as well as chromosomes 14, 15, 21 and 22) belongs to the group of acrocentric chromosomes. -
X-Linked Transposition of the Great Arteries and Incomplete Penetrance Among Males with a Nonsense Mutation in ZIC3
European Journal of Human Genetics (2000) 8, 704–708 y © 2000 Macmillan Publishers Ltd All rights reserved 1018–4813/00 $15.00 www.nature.com/ejhg ARTICLE X-linked transposition of the great arteries and incomplete penetrance among males with a nonsense mutation in ZIC3 Andr´e M´egarban´e1, Nabiha Salem1, Edouard Stephan2, Ramzi Ashoush3, Didier Lenoir4, Val´erie Delague1, Roland Kassab4, Jacques Loiselet1 and Patrice Bouvagnet4,5 1Unit´e de G´en´etique M´edicale, Facult´e de M´edecine, Universit´e Saint-Joseph, Beirut; 2Facult´e de M´edecine, Universit´e Saint-Joseph, Beirut; 3Service de Chirurgie Cardio-Vasculaire et de Cardiologie, Hˆotel-Dieu de France, Beirut, Lebanon; 4Laboratoire de G´en´etique Mol´eculaire Humaine, Facult´e de M´edecine et Pharmacie, Universit´e Claude Bernard, Lyon; 5Service de Cardiologie P´ediatrique, Hˆopital Louis Pradel, Bron, France We report on a Lebanese family in which two maternal cousins suffered and died very early in life from cardiac malformations. Both presented with a transposition of the great arteries associated with one or several other cardiac defects. Various minor midline defects were also observed, but there were no situs abnormalities other than a persistent left superior vena cava in one. A maternal uncle of these two babies was born cyanotic and died on the third post-natal day. Analysis of the ZIC3 gene, revealed the presence of a mutation in the second exon leading to a truncation of the protein. Surprisingly, another maternal uncle of the two affected cousins also had the mutation but was not clinically affected. -
Rabbit Anti-Zic1/FITC Conjugated Antibody
SunLong Biotech Co.,LTD Tel: 0086-571- 56623320 Fax:0086-571- 56623318 E-mail:[email protected] www.sunlongbiotech.com Rabbit Anti-Zic1/FITC Conjugated antibody SL11609R-FITC Product Name: Anti-Zic1/FITC Chinese Name: FITC标记的Zinc finger protein201抗体 ZNF201; Odd paired homolog Drosophila; Zic 1; ZIC; Zic family member 1 (odd- paired Drosophila homolog); Zic family member 1; Zic protein member 1; zic1; Alias: ZIC1_HUMAN; Zinc finger protein 201; Zinc finger protein of the cerebellum 1; Zinc finger protein ZIC 1; Zinc finger protein ZIC1; ZNF 201. Organism Species: Rabbit Clonality: Polyclonal React Species: Human,Mouse,Rat,Chicken,Pig,Cow, ICC=1:50-200IF=1:50-200 Applications: not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. Molecular weight: 48kDa Form: Lyophilized or Liquid Concentration: 1mg/ml immunogen: KLH conjugated synthetic peptide derived from human Zic1 (201-286aa) Lsotype: IgG Purification: affinitywww.sunlongbiotech.com purified by Protein A Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year Storage: when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. background: Zic1 is a C2H2 zinc finger transcription factor that controls the expansion of neuronal precursors by inhibiting the progression of neuronal differentiation. Zic1 determines the Product Detail: cerebellar folial pattern by influencing proliferation in the external germinal layer (EGL). -
Transcriptional Expression of Zics As an Independent Indicator of Survival in Gliomas Zhaocheng Han, Jingnan Jia, Yangting Lv, Rongyanqi Wang & Kegang Cao*
www.nature.com/scientificreports OPEN Transcriptional expression of ZICs as an independent indicator of survival in gliomas Zhaocheng Han, Jingnan Jia, Yangting Lv, Rongyanqi Wang & Kegang Cao* The functional signifcance of the zinc-fnger of the cerebellum (ZIC) gene family in gliomas remains to be elucidated. Clinical data from patients with gliomas, containing expression levels of ZIC genes, were extracted from CCLE, GEPIA2 and The Human Protein Atlas (HPA). Univariate survival analysis adjusted by Cox regression via OncoLnc was used to determine the prognostic signifcance of ZIC expression. We used cBioPortal to explore the correlation between gene mutations and overall survival (OS). ZIC expression was found to be related to immune cell infltration in gliomas via TIMER analysis. GO term and KEGG pathway enrichment analyzes were performed with Metascape. PPI networks were constructed using STRING. The expression levels of ZIC1/3/4/5 in gliomas were signifcantly diferent from those in normal samples. High expression levels of ZIC1/5 were associated with poor OS in brain low-grade glioma (LGG) patients, while low ZIC3 expression combined was related to favorable OS in glioblastoma multiforme (GBM). ZIC alterations were associated with poor prognosis in LGG patients and related to favorable prognosis in GBM patients. We observed that the expression of ZICs was related to immune cell infltration in glioma patients. ZICs were enriched in several pathways and biological processes involving Neuroactive ligand-receptor interaction (hsa04080). The PPI network revealed that some proteins coexpressed with ZICs played a role in the pathogenesis of gliomas. Diferences in the expression levels of ZIC genes could provide a signifcant marker for predicting prognosis in gliomas. -
The Unfolding Clinical Spectrum of Holoprosencephaly Due To
European Journal of Human Genetics (2010) 18, 999–1005 & 2010 Macmillan Publishers Limited All rights reserved 1018-4813/10 www.nature.com/ejhg ARTICLE The unfolding clinical spectrum of holoprosencephaly duetomutationsinSHH, ZIC2, SIX3 and TGIF genes Aime´e DC Paulussen*,1, Constance T Schrander-Stumpel1, Demis CJ Tserpelis1, Matteus KM Spee1, Alexander PA Stegmann1, Grazia M Mancini2, Alice S Brooks2, Margriet Colle´e2, Anneke Maat-Kievit2, Marleen EH Simon2, Yolande van Bever2, Irene Stolte-Dijkstra3, Wilhelmina S Kerstjens-Frederikse3, Johanna C Herkert3, Anthonie J van Essen3, Klaske D Lichtenbelt4, Arie van Haeringen5, Mei L Kwee6, Augusta MA Lachmeijer6, Gita MB Tan-Sindhunata6, Merel C van Maarle7, Yvonne HJM Arens1, Eric EJGL Smeets1, Christine E de Die-Smulders1, John JM Engelen1, Hubertus J Smeets1 and Jos Herbergs1 Holoprosencephaly is a severe malformation of the brain characterized by abnormal formation and separation of the developing central nervous system. The prevalence is 1:250 during early embryogenesis, the live-born prevalence is 1:16 000. The etiology of HPE is extremely heterogeneous and can be teratogenic or genetic. We screened four known HPE genes in a Dutch cohort of 86 non-syndromic HPE index cases, including 53 family members. We detected 21 mutations (24.4%), 3 in SHH,9inZIC2 and 9 in SIX3. Eight mutations involved amino-acid substitutions, 7 ins/del mutations, 1 frame-shift, 3 identical poly-alanine tract expansions and 2 gene deletions. Pathogenicity of mutations was presumed based on de novo character, predicted non- functionality of mutated proteins, segregation of mutations with affected family-members or combinations of these features. -
Inhibition of Myogenesis by a Soluble Wnt Antagonist
Development 126, 4257-4265 (1999) 4257 Printed in Great Britain © The Company of Biologists Limited 1999 DEV2454 Functional association of retinoic acid and hedgehog signaling in Xenopus primary neurogenesis Paula G. Franco*, Alejandra R. Paganelli*, Silvia L. López and Andrés E. Carrasco‡ Laboratorio de Embriología Molecular, Instituto de Biología Celular y Neurociencias, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, 3° piso, 1121, Buenos Aires, Argentina *These authors have contributed equally to this work and are listed in alphabetical order ‡Author for correspondence (e-mail: [email protected]) Accepted 17 July; published on WWW 7 September 1999 SUMMARY Previous work has shown that the posteriorising agent downregulated Gli3 and upregulated Zic2. Thus, retinoic retinoic acid can accelerate anterior neuronal acid and hedgehog signaling have opposite effects on the differentiation in Xenopus laevis embryos (Papalopulu, N. prepattern genes Gli3 and Zic2 and on other genes acting and Kintner, C. (1996) Development 122, 3409-3418). To downstream in the neurogenesis cascade. In addition, elucidate the role of retinoic acid in the primary retinoic acid cannot rescue the inhibitory effect of neurogenesis cascade, we investigated whether retinoic acid NotchICD, Zic2 or sonic hedgehog on primary neurogenesis. treatment of whole embryos could change the spatial Our results suggest that retinoic acid acts very early, expression of a set of genes known to be involved in upstream of sonic hedgehog, and we propose a model for neurogenesis. We show that retinoic acid expands the N- regulation of differentiation and proliferation in the neural tubulin, X-ngnr-1, X-MyT1, X-Delta-1 and Gli3 domains plate, showing that retinoic acid might be activating and inhibits the expression of Zic2 and sonic hedgehog primary neurogenesis by repressing sonic hedgehog in the neural ectoderm, whereas a retinoid antagonist expression. -
Product Description SALSA MLPA Probemix P267
MRC-Holland ® Product Description version B1-01; Issued 11 April 2018 MLPA Product Description SALSA ® MLPA ® Probemix P267-B1 Dandy-Walker To be used with the MLPA General Protocol. Version B1. As compared to version A3, probes for FOXC1 and VLDLR exon 9 have been added, one probe for ZIC1 exon 1 has been removed, and several probes for VLDLR , ZIC1 , ZIC4 and SMARCA2 have been replaced. Seven reference probes have been replaced and two reference probes have been added. In addition, several probes have been changed in length, but no or small change in sequence detected. For complete product history see page 8. Catalogue numbers: • P267-025R: SALSA MLPA Probemix P267 Dandy-Walker, 25 reactions. • P267-050R: SALSA MLPA Probemix P267 Dandy-Walker, 50 reactions. • P267-100R: SALSA MLPA Probemix P267 Dandy-Walker, 100 reactions. To be used in combination with a SALSA MLPA reagent kit, available for various number of reactions. MLPA reagent kits are either provided with FAM or Cy5.0 dye-labelled PCR primer, suitable for Applied Biosystems and Beckman capillary sequencers, respectively (see www.mlpa.com ). Certificate of Analysis: Information regarding storage conditions, quality tests, and a sample electropherogram from the current sales lot is available at www.mlpa.com. Precautions and warnings: For professional use only. Always consult the most recent product description AND the MLPA General Protocol before use: www.mlpa.com . It is the responsibility of the user to be aware of the latest scientific knowledge of the application before drawing any conclusions from findings generated with this product. General Information: The SALSA MLPA Probemix P267 Dandy-Walker is a research use only (RUO) assay for the detection of deletions or duplications in the ZIC1 , ZIC4 , VLDLR , and FOXC1 genes, which are associated with Dandy-Walker malformation. -
Mutations in ZIC2 in Human Holoprosencephaly: Description of a Novel ZIC2 Specific Phenotype and Comprehensive Analysis of 157 Individuals
Mutations in ZIC2 in human holoprosencephaly: description of a novel ZIC2 specific phenotype and comprehensive analysis of 157 individuals. Benjamin Solomon, Felicitas Lacbawan, Sandra Mercier, Nancy Clegg, Mauricio Delgado, Kenneth Rosenbaum, Christèle Dubourg, Véronique David, Ann Haskins Olney, Lars-Erik Wehner, et al. To cite this version: Benjamin Solomon, Felicitas Lacbawan, Sandra Mercier, Nancy Clegg, Mauricio Delgado, et al.. Mu- tations in ZIC2 in human holoprosencephaly: description of a novel ZIC2 specific phenotype and comprehensive analysis of 157 individuals.. Journal of Medical Genetics, BMJ Publishing Group, 2010, 47 (8), pp.513-24. 10.1136/jmg.2009.073049. inserm-00439659 HAL Id: inserm-00439659 https://www.hal.inserm.fr/inserm-00439659 Submitted on 9 Dec 2009 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Mutations in ZIC2 in Human Holoprosencephaly: Comprehensive Analysis of 153 Individuals and Description of a Novel ZIC2-Specfic Phenotype Benjamin D. Solomon1#, Felicitas Lacbawan1,2#, Sandra Mercier3,4, Nancy J. Clegg5, Mauricio R. Delgado5, Kenneth Rosenbaum6, Christèle Dubourg3, Veronique David3, Ann Haskins Olney7, Lars-Erik Wehner8,9, Ute Hehr8,9, Sherri Bale10, Aimee Paulussen11, Hubert J. Smeets11, Emily Hardisty12, Anna Tylki-Szymanska13, Ewa Pronicka13, Michelle Clemens14, Elizabeth McPherson15, Raoul C.M.